Balthaser Kevin insider trades
Balthaser Kevin has filed 16 Form 4s with the SEC that we hold, all for Aclaris Therapeutics, Inc. (ACRS), as Chief Financial Officer. Across all of them we count 1 purchase worth $75.0K and 2 sales worth $23.6K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 9,490 shares of Aclaris Therapeutics, Inc. worth $75.0K, dated 2023-09-06. The first filing on our record is dated 2023-02-03 and the latest 2026-03-03.
Aclaris Therapeutics, Inc. (ACRS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-03-02 | S, sale reported on Form 4 | 1,000 | $12.3K | 2023-03-03 |
| 2023-03-03 | S, sale reported on Form 4 | 894 | $11.3K | 2023-03-03 |
| 2023-09-06 | P, purchase reported on Form 4 | 9,490 | $75.0K | 2023-09-07 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1957554) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms